Researchers Can Grow Functional Stomach and Intestinal Tissues to Study Diseases, New Drugs
Scientists report in Nature using pluripotent stem cells to generate human stomach tissues in a petri dish that produce acid and digestive enzymes.
Publishing their findings online Jan. 4, researchers at Cincinnati Children’s Hospital Medical Center grew tissues from the stomach’s corpus/fundus region. The study comes two years after the same team generated the stomach’s hormone-producing region (the antrum).
The discovery means investigators now can grow both parts of the human stomach to study disease, model new treatments and understand human development and health in ways never before possible.
“Now that we can grow both antral- and corpus/fundic-type human gastric mini-organs, it’s possible to study how these human gastric tissues interact physiologically, respond differently to infection, injury and react to pharmacologic treatments,” said Jim Wells, PhD, principal investigator and director of the Pluripotent Stem Cell Facility at Cincinnati Children’s. “Diseases of the stomach impact millions of people in the United States and gastric cancer is the third leading cause of cancer-related deaths worldwide.”
The current study caps a series of discoveries since 2010 in which research teams led or co-led by Wells used human pluripotent stem cells (hPSC) – which can become any cell type in the body – to engineer regions of the human stomach and intestines. They are using the tissues to identify causes and treatments for diseases of the human gastrointestinal tract.
This includes a study published Nov. 21, 2016 by Nature Medicine, in which scientists generated human intestine with an enteric nervous system. These highly functional tissues are able to absorb nutrients and demonstrate peristalsis, the intestinal muscular contractions that move food from one end of the GI tract to the other.
The primary focus of Wells’ laboratory is to study how organs form during embryonic development. This includes the esophagus, stomach, pancreas and intestines. Wells and his colleagues have a particular interest in finding new treatments for genetic forms of diseases like monogenic diabetes and Hirschsprung’s disease.
Starting from Scratch
A major challenge investigators encountered in the current study is a lack of basic knowledge on how the stomach normally forms during embryonic development.
“We couldn’t engineer human stomach tissue in a petri dish until we first identified how the stomach normally forms in the embryo,” explains Wells.
To fill that gap, the researchers used mice to study the genetics behind embryonic development of the stomach.
In doing so, they discovered that a fundamental genetic pathway (WNT/?-catenin) plays an essential role in directing development of the corpus/fundus region of the stomach in mouse embryos. After this, researchers manipulated the WNT/?-catenin in a petri dish to trigger the formation of human fundus organoids from pluripotent stem cells.
Study authors then further refined the process, identifying additional molecular signaling pathways that drive formation of critical stomach cell types of the fundus. These include chief cells, which produce a key digestive enzyme called pepsin, and parietal cells. Parietal cells secrete hydrochloric acid for digestion and intrinsic factor to help the intestines absorb vitamin B-12, which is critical for making blood cells and maintaining a healthy nervous system.
Wells said that it takes about six weeks for stem cells to form gastric-fundus tissues in a petri dish.
Researchers now plan to study the ability of tissue-engineered human stomach organoids to model human gastric diseases by transplanting them into mouse models. In particular, Wells and his collaborator Yana Zavros, PhD, associate professor at the University of Cincinnati, want to explore how the fundus organoids respond after being infected with H (Helicobacter) pylori bacteria. H pylori causes chronic gastritis, stomach ulcers and is a major risk factor for the development of stomach cancer.
Stomach organoids can also be used in combination with intestinal organoids to study how the body controls digestion and proper nutrient uptake, as well as a variety of other medical conditions affecting the gastrointestinal tract. These include gastrointestinal motility disorders, inflammatory diseases, drug uptake studies, and studying helpful microbes (probiotics) as well as harmful ones.
[osd_subscribe categories=’tissue-engineering’ placeholder=’Email Address’ button_text=’Subscribe Now for any new posts on the topic “TISSUE ENGINEERING”‘]
Receive an email update when we add a new TISSUE ENGINEERING article.
The Latest on: Tissue engineering
via Google News
The Latest on: Tissue engineering
- New options for laryngeal regeneration using 3D printingon August 2, 2022 at 1:12 pm
Mayo Clinic is using 3D printing as a new option to heal the larynx after cancer or traumatic injury. David Lott, M.D., a Mayo Clinic otolaryngologist and head and neck surgeon, is an expert who can ...
- 3D Tissue Engineering: How It Benefits Breast Cancer Survivors?on August 2, 2022 at 9:26 am
But a new advanced treatment model is now gaining ground in biomedicine, known as tissue engineering. Being at the confluence of cutting-edge medical science, engineering, and advanced biology, tissue ...
- Electrical Tissue Dissociation Outperforms Mechanical, Chemical Approacheson August 1, 2022 at 10:03 pm
While there are existing mechanical and chemical means researchers can use to dissociate tissues into viable, useful individual cells—vortexers, centrifuges, hot plates, the right combination of ...
- Options for laryngeal regenerationon August 1, 2022 at 5:00 pm
We see a lot of patients who could benefit from some level of laryngeal regeneration." After surgery to remove the larynx — a procedure known as a laryngectomy — patients must breathe through a hole ...
- Tissue Engineering Market Insights 2022 With Top Leaders| Growth Opportunity with 18.69% CAGR, Share and Growth till 2028on August 1, 2022 at 7:50 am
The MarketWatch News Department was not involved in the creation of this content. Aug 01, 2022 (The Expresswire) -- Global Tissue Engineering Market Analysis and Insights: Worldwide "Tissue ...
- RTT Medical joins RegenMed Hub Innovation Acceleratoron July 31, 2022 at 5:00 pm
RTT Medical is the newest tenant of the Innovation Accelerator, a support ecosystem created by the RegenMed Development Organization (ReMDO) to help companies with new or emerging regenerative ...
- Tissue Engineering Market [+Key Strategies And Developments] | Regional Segment By 2031on July 29, 2022 at 2:23 am
The global tissue engineering market size was computed at USD 9900 Million in 2019 and is expected to witness a CAGR of 14.2% from 2020 to 2027 NEW YORK CITY, NEW YORK, UNITED STATES, July 29 ...
- Tissue Engineering Scaffold Service Now Available at Matexcelon July 28, 2022 at 10:00 am
Scientists in the field of regenerative medicine research, now have access to Matexcel’s newly released tissue engineering scaffold service. Matexcel is a leading services and products provider in ...
- Tissue Engineering Market Size In 2022 | No of Pages 104 | long-term Calculated Business Plan by Recognizing Shifting Trends up to 2029on July 28, 2022 at 5:40 am
Jul 28, 2022 (The Expresswire) -- "Tissue Engineering Market" Insights 2022 Report Contains104pages With Applications [Cord Blood and Cell Banking, ...
via Bing News